Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR9 | Q9NR96 | 6/20 | 0.42 |
| ▸ | TLR8 | Q9NR97 | 6/20 | 0.42 |
| ▸ | TLR7 | Q9NYK1 | 6/20 | 0.42 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.36 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 6/20 | 0.34 |
| ▸ | UHRF1 | Q96T88 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.33 |
| ▸ | PDK4 | Q16654 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21212290 | 0.79 | UHRF1 (0.40) | TLR9TLR8TLR7CYP17A1CHRNA7 | |
| SCHEMBL25023846 | 0.77 | MAPT (0.40) | TLR9TLR8TLR7TRPV1 | |
| SCHEMBL7940997 | 0.76 | CHRNA7 (0.36) | TLR9TLR8TLR7CYP17A1CHRNA7 | |
| SCHEMBL26621158 | 0.76 | SCN9A (0.37) | CYP17A1 | |
| SCHEMBL18017351 | 0.75 | UHRF1 (0.45) | TLR9TLR8TLR7CYP17A1CHRNA7 | |
| SCHEMBL20733724 | 0.73 | CHRNA7 (0.40) | CYP17A1CHRNA7TRPV1UHRF1PDK2 | |
| SCHEMBL26742436 | 0.73 | CNR2 (0.39) | CYP17A1 | |
| SCHEMBL31676144 | 0.73 | CNR2 (0.39) | CYP17A1 | |
| SCHEMBL31676221 | 0.73 | TLR9 (0.36) | TLR9TLR8TLR7CYP17A1 | |
| SCHEMBL19225568 | 0.72 | CHRNA7 (0.39) | CYP17A1CHRNA7UHRF1PDK2PDK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106255685-A | For preventing or treat the Triaminopyrimidine compound of malaria | MMV疟疾药物投资公司 | 2016-12-21 | — | — | CN | disclosed |